Omri Faingold

1PUBLICATIONS
2CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 05, 2018
The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice.

Etai Rotem, Omri Faingold, Meital Charni

Pageof 1

Frequent Collaborators

1 joint publications

Daniel Harari

1 joint publications

Yechiel Shai